DCI

Analyst Note: Donaldson Company, Inc. (DCI)

Date: 2026-06-13 Price: $85.52

1. Structural Readiness

State: Context-Only Conservative Entry: — (Awaiting confirmed breakout) Current Price: $85.52 Extension: — Breakout Level: — (Not yet fired) ATR Current: 2.4% (Sub-threshold volatility)

Analysis:

2. Thesis Layer

Thesis Classification: Tactical / Setup-Led Secular Exposure: None Named

At this date, there is no named secular thesis driving this specific setup. This is a tactical, setup-led name. The conviction must be derived strictly from the quality of the structural setup (the forming coil) and the immediate business fundamentals reported in the most recent earnings cycle. We do not invent a macro thesis; we judge the name on its ability to execute its current strategy and the technical readiness of the price structure.

3. The Business

Donaldson Company, Inc. is a global leader in technology-led filtration products and solutions, serving a broad range of industries including construction, mining, agriculture, transportation, aerospace, defense, and life sciences.

Business Model & Segments: The company operates through three primary segments, as detailed in the fiscal 2025 and 2026 filings:

• Mobile Solutions (62.1% of FY2025 sales): Serves OEMs in construction, mining, agriculture, and transportation, as well as independent distributors and dealer networks. This segment includes Off-Road, On-Road, and Aftermarket business units.
• Industrial Solutions (29.9% of FY2025 sales): Organized by product type, including Industrial Air Filtration, Industrial Gases, Industrial Hydraulics, Power Generation, and Aerospace and Defense products.
• Life Sciences (8.0% of FY2025 sales): Serves Food and Beverage, Disk Drive, Vehicle Electrification, and Medical Device markets.

Recent Performance & Strategic Moves (Source: Earnings Transcript 2026-06-02 & SEC Filings):

• Record Sales: The company reported inclusive record sales of over $3.8 billion, a 4% increase year-over-year.
• Growth Drivers: Growth was driven by high-margin businesses, specifically Mobile Solutions (up 4.8% in the nine months ended April 30, 2026) and Life Sciences (up 14.0% in the same period).
• Margin Expansion: Operating margins expanded versus 2025, with earnings per share roughly 8% above the prior year.
• Acquisition Strategy: On May 4, 2026, the Company acquired Filtration Group's Facet Filtration business for approximately $828.7 million in cash. This acquisition increases exposure to durable, growing end markets (aerospace, power generation) and strengthens the aftermarket position, with approximately 70% of Facet's revenues driven by recurring, regulated replacement part sales.
• Backlog & Orders: Management exited the quarter with "robust order volumes" and "elevated backlogs."
• Guidance: Management expects consolidated organic sales to grow between 3% to 5%, with the midpoint being about 1% higher than prior guidance.
• Cost Initiatives: Industrial-based initiatives are expected to generate annualized benefits of about $10 million once run-rate productivity is hit during fiscal 27.

Financial Health: The acquisition was funded by issuing approximately $820.0 million of new debt, bringing total long-term debt to approximately $1.4 billion. Management stated the company remained in compliance with all applicable financial covenants. Gross margin for the nine months ended April 30, 2026, was 34.0%, down slightly from 35.0% in the prior year, likely reflecting the integration of the new acquisition or mix shifts, though operating margin expanded.

4. Archetype and Conviction

Archetype: Quality Compounder Fit Rationale: The name fits the Quality Compounder archetype due to its consistent execution of margin expansion, strong free cash flow generation (implied by the ability to fund an $828M acquisition in cash), and a business model heavily weighted toward recurring aftermarket sales (particularly in Mobile Solutions and the newly acquired Facet business). The "70% recurring revenue" profile of the Facet acquisition reinforces the compounder nature of the business.

Conviction Stack:

• Thesis Strength: Low (Tactical only, no macro thesis).
• Evidence Quality: High. The earnings transcript and SEC filings provide robust, point-in-time data on sales growth, margin expansion, and successful M&A integration.
• Structural Quality: Moderate. The setup is "Forming," meaning the structure is present but unconfirmed. The sub-threshold ATR (2.4%) suggests the market is not yet pricing in a high-conviction breakout, which can be a positive for accumulation but a negative for immediate momentum.
• Rerating Potential: Moderate. The combination of record sales, margin expansion, and a strategic acquisition that adds high-margin recurring revenue provides a fundamental basis for a rerating, provided the technical breakout occurs.

Valuation Context: Forward consensus EPS for FY1 is $3.95 and FY2 is $4.36. At a current price of $85.52, the stock trades at approximately 21.6x FY1 EPS and 19.6x FY2 EPS. This valuation is consistent with a Quality Compounder in the Industrials sector, assuming the growth trajectory holds.

5. Invalidations, Strengths, and Gaps

What Would Invalidate the Case:

• Fundamental: A significant miss on the 3-5% organic sales guidance or a failure to maintain operating margin expansion post-acquisition.
• Balance Sheet: A breach of financial covenants due to the increased debt load from the Facet acquisition.

What Would Strengthen the Case:

• Technical: A confirmed breakout (close above the resistance level) with volume, confirming the "Forming" coil into a "Confirmed" coil.
• Fundamental: Confirmation that the $10 million annualized benefit from industrial initiatives is realized ahead of schedule.
• Strategic: Further evidence of the "large competitive win" with the North American fleet operator translating into sustained order growth.

Gaps in Evidence:

• Integration Details: While the acquisition is noted, there is no specific data on the immediate impact of the Facet acquisition on the Q2 2026 gross margin (which dipped to 34.0%) or the timeline for full integration synergies.
• Sector Context: No specific peer comparison data is available to contextualize the 34.0% gross margin relative to industry peers.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: Medium Key evidence: Record sales of $3.8B with 4% growth; Operating margin expansion and EPS up 8%; Strategic acquisition of Facet Filtration adding 70% recurring revenue; Robust order volumes and elevated backlogs. Key risks: Sub-threshold ATR (2.4%) indicating low volatility and potential for slow price action; Technical setup is "Forming" and not yet confirmed; Gross margin compression to 34.0% despite sales growth; Increased debt load of $1.4B following acquisition. Sizing hint: Position size should reflect the "Forming" status; treat as a partial position awaiting technical confirmation rather than a full conviction entry. Expected path: Management expects 3-5% organic sales growth and $10M in annualized benefits from initiatives; price likely to consolidate near current levels until a breakout confirms the structural setup. Expected horizon: 3 to 6 months for the forming coil to resolve into a confirmed breakout or invalidation.